425 related articles for article (PubMed ID: 16804051)
1. Regulatory T cells in human autoimmune thyroid disease.
Marazuela M; García-López MA; Figueroa-Vega N; de la Fuente H; Alvarado-Sánchez B; Monsiváis-Urenda A; Sánchez-Madrid F; González-Amaro R
J Clin Endocrinol Metab; 2006 Sep; 91(9):3639-46. PubMed ID: 16804051
[TBL] [Abstract][Full Text] [Related]
2. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
3. Levels of regulatory T cells CD69(+)NKG2D(+)IL-10(+) are increased in patients with autoimmune thyroid disorders.
Rodríguez-Muñoz A; Vitales-Noyola M; Ramos-Levi A; Serrano-Somavilla A; González-Amaro R; Marazuela M
Endocrine; 2016 Mar; 51(3):478-89. PubMed ID: 26100786
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
6. In vitro expansion of CD4+CD25highFOXP3+CD127low/- regulatory T cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans.
Hougardy JM; Verscheure V; Locht C; Mascart F
Microbes Infect; 2007 Sep; 9(11):1325-32. PubMed ID: 17890131
[TBL] [Abstract][Full Text] [Related]
7. [Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR(+)CD25⁻ cell subset in patients with systemic lupus erythematosus].
Alunno A; Nocentini G; Bistoni O; Bianchini R; Bartoloni Bocci E; Riccardi C; Gerli R
Reumatismo; 2010; 62(3):195-201. PubMed ID: 21052566
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis-induced decrease of intrathyroidal CD4(+)CD25(+) regulatory T cells in autoimmune thyroid diseases.
Nakano A; Watanabe M; Iida T; Kuroda S; Matsuzuka F; Miyauchi A; Iwatani Y
Thyroid; 2007 Jan; 17(1):25-31. PubMed ID: 17274744
[TBL] [Abstract][Full Text] [Related]
9. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
10. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma.
Lee JH; Yu HH; Wang LC; Yang YH; Lin YT; Chiang BL
Clin Exp Immunol; 2007 Apr; 148(1):53-63. PubMed ID: 17349011
[TBL] [Abstract][Full Text] [Related]
11. Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency.
Arandi N; Mirshafiey A; Abolhassani H; Jeddi-Tehrani M; Edalat R; Sadeghi B; Shaghaghi M; Aghamohammadi A
Scand J Immunol; 2013 May; 77(5):405-12. PubMed ID: 23432692
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
13. The activation of monocyte and T cell networks in patients with bipolar disorder.
Drexhage RC; Hoogenboezem TH; Versnel MA; Berghout A; Nolen WA; Drexhage HA
Brain Behav Immun; 2011 Aug; 25(6):1206-13. PubMed ID: 21443944
[TBL] [Abstract][Full Text] [Related]
14. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome.
Alunno A; Petrillo MG; Nocentini G; Bistoni O; Bartoloni E; Caterbi S; Bianchini R; Baldini C; Nicoletti I; Riccardi C; Gerli R
Rheumatology (Oxford); 2013 Aug; 52(8):1387-96. PubMed ID: 23674818
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
[TBL] [Abstract][Full Text] [Related]
17. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
18. Patients with Systemic Lupus Erythematosus Show Increased Levels and Defective Function of CD69
Vitales-Noyola M; Oceguera-Maldonado B; Niño-Moreno P; Baltazar-Benítez N; Baranda L; Layseca-Espinosa E; Abud-Mendoza C; González-Amaro R
Mediators Inflamm; 2017; 2017():2513829. PubMed ID: 29038617
[TBL] [Abstract][Full Text] [Related]
19. IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin.
Clark RA; Kupper TS
Blood; 2007 Jan; 109(1):194-202. PubMed ID: 16968902
[TBL] [Abstract][Full Text] [Related]
20. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome.
Commodaro AG; Peron JP; Genre J; Arslanian C; Sanches L; Muccioli C; Rizzo LV; Belfort R
Scand J Immunol; 2010 Jul; 72(1):31-7. PubMed ID: 20591073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]